Login / Signup

Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.

Noor Barak AlmandilMuhammad TahaRai Khalid FarooqAmani AlhibshiMohamed IbrahimEl Hassane AnouarMohammed GollapalliFazal RahimMuhammad NawazSyed Adnan Ali ShahQamar Uddin AhmedZainul Amiruddin Zakaria
Published in: Molecules (Basel, Switzerland) (2019)
We have synthesized quinoxaline analogs (1⁻25), characterized by ¹H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.
Keyphrases
  • molecular docking
  • molecular dynamics simulations
  • structure activity relationship
  • multiple sclerosis
  • mass spectrometry
  • magnetic resonance
  • ms ms
  • high intensity
  • dna binding